Cite
HARVARD Citation
Dal Lago, L. et al. (2022). Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial. Journal of geriatric oncology. 13 (5), pp. 582-593. [Online].